Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Natasha Banga, Rohan Kanade, Anishka Kappalayil, Irina Timofte, Adrian Lawrence, Srinivas Bollineni, Vaidehi Kaza, Fernando Torres |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Association of Community Distress With Lung Transplant Waitlist Acceptance
por: William M. Brandon, et al.
Publicado: (2025)
por: William M. Brandon, et al.
Publicado: (2025)
Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience
por: Colin T. Dunn, et al.
Publicado: (2024)
por: Colin T. Dunn, et al.
Publicado: (2024)
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025)
por: Vaisak O. Nair, et al.
Publicado: (2025)
Failed Extubation After Lung Transplantation in the United States: A Six‐Year National Analysis Using the UNOS Database
por: Amit Banga, et al.
Publicado: (2026)
por: Amit Banga, et al.
Publicado: (2026)
Characteristics and Clinical Outcomes of Postoperative Pleural Space Infections Among Lung Transplant Recipients
por: Miranda Arzate, et al.
Publicado: (2026)
por: Miranda Arzate, et al.
Publicado: (2026)
Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
por: Iris Feng, et al.
Publicado: (2025)
por: Iris Feng, et al.
Publicado: (2025)
A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
por: Afolarin A. Otunla, et al.
Publicado: (2026)
por: Afolarin A. Otunla, et al.
Publicado: (2026)
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
por: John‐Anthony Coppola, et al.
Publicado: (2025)
por: John‐Anthony Coppola, et al.
Publicado: (2025)
Assessing the Quality of Life in Adult Lung Transplant Recipients Quality of Life Post‐Lung Transplant
por: Bashayer M. Al‐Shweeman, et al.
Publicado: (2025)
por: Bashayer M. Al‐Shweeman, et al.
Publicado: (2025)
Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus
por: Zeba Nauroz, et al.
Publicado: (2025)
por: Zeba Nauroz, et al.
Publicado: (2025)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
por: Abdallah Mughrabi, et al.
Publicado: (2026)
por: Abdallah Mughrabi, et al.
Publicado: (2026)
The Impact of Donor‐Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans‐Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases
por: Andrew M. Courtwright, et al.
Publicado: (2024)
por: Andrew M. Courtwright, et al.
Publicado: (2024)
Neighborhood‐Level Deprivation Impacts Graft and Patient Outcomes Among Pediatric Liver Transplant Recipients
por: Leandra Bitterfeld, et al.
Publicado: (2024)
por: Leandra Bitterfeld, et al.
Publicado: (2024)
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
por: Madeleine R. Heldman, et al.
Publicado: (2024)
por: Madeleine R. Heldman, et al.
Publicado: (2024)
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)
por: Lemuel R. Non, et al.
Publicado: (2024)
Long‐Term Outcomes After Kidney Transplantation in a Recipient With Birt–Hogg–Dubé Syndrome
por: Armando Salim Munoz Abraham, et al.
Publicado: (2025)
por: Armando Salim Munoz Abraham, et al.
Publicado: (2025)
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
por: Renato Pascale, et al.
Publicado: (2026)
por: Renato Pascale, et al.
Publicado: (2026)
Single‐Center Outcomes of Conversion to Belatacept in Kidney Transplant Recipients
por: Eve Carciofi, et al.
Publicado: (2025)
por: Eve Carciofi, et al.
Publicado: (2025)
Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients
por: Stefan Kuhnert, et al.
Publicado: (2024)
por: Stefan Kuhnert, et al.
Publicado: (2024)
Comparison of Early Conversion to LCP‐Tacrolimus (ENVARSUS XR) to Immediate‐Release Tacrolimus in Lung Transplant Recipients
por: Tyler C. Lewis, et al.
Publicado: (2025)
por: Tyler C. Lewis, et al.
Publicado: (2025)
Long-Term Outcomes of Recipients of Liver Transplants from Living Donors Treated with a Very Low-Calorie Diet
por: Hannah Wozniak, et al.
Publicado: (2024)
por: Hannah Wozniak, et al.
Publicado: (2024)
Clinical Implications of Early vs Late Development of Donor‐Specific Antibodies Among Lung Transplant Recipients: A Single‐Center Experience
por: Devika Sindu, et al.
Publicado: (2026)
por: Devika Sindu, et al.
Publicado: (2026)
Machine Learning for 1‐Year Graft Failure Prediction in Lung Transplant Recipients: The Korean Organ Transplantation Registry
por: Dasom Noh, et al.
Publicado: (2025)
por: Dasom Noh, et al.
Publicado: (2025)
Impact of Dynapenia on Short‐Term Changes in Handgrip Strength Among Japanese Kidney Transplant Recipients: A Cross‐Sectional Study
por: Masatoshi Matsunami, et al.
Publicado: (2025)
por: Masatoshi Matsunami, et al.
Publicado: (2025)
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients
por: Rachael Gordon, et al.
Publicado: (2024)
por: Rachael Gordon, et al.
Publicado: (2024)
“Reevaluating Diagnostic Criteria and Prophylactic Strategies for Aspergillus in Lung Transplant Recipients”
por: Asad Iqbal, et al.
Publicado: (2025)
por: Asad Iqbal, et al.
Publicado: (2025)
Cytomegalovirus, the Troll of Transplantation and Cellular Therapy?
por: Joseph Sassine, et al.
Publicado: (2025)
por: Joseph Sassine, et al.
Publicado: (2025)
Life Satisfaction and Psychosocial Adjustment in Lung Transplant Recipients: Work, Family, and Sexual Life
por: Aleksandra Stańska, et al.
Publicado: (2026)
por: Aleksandra Stańska, et al.
Publicado: (2026)
Mismatched Blood Types between Donors and Recipients Increase the Risk of BK Viremia One Year after Kidney Transplantation
por: Ruth Rahamimov, et al.
Publicado: (2026)
por: Ruth Rahamimov, et al.
Publicado: (2026)
The Impact of Epstein–Barr Virus Serostatus Mismatch in Adult Kidney Transplant Recipients: An Analysis of the 2012–2022 OPTN Database
por: Namrata Parikh, et al.
Publicado: (2025)
por: Namrata Parikh, et al.
Publicado: (2025)
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Marilyne Daher, et al.
Publicado: (2025)
por: Marilyne Daher, et al.
Publicado: (2025)
Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients
por: Farid Foroutan, et al.
Publicado: (2025)
por: Farid Foroutan, et al.
Publicado: (2025)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
por: Suneri J. Amin, et al.
Publicado: (2025)
por: Suneri J. Amin, et al.
Publicado: (2025)
Donation after Circulatory Death Donors Are Associated With Increased 1‐Year Mortality After Lung Transplantation: A UNOS‐Based Risk Stratification Study
por: Amit Banga, et al.
Publicado: (2025)
por: Amit Banga, et al.
Publicado: (2025)
Impact of Donor and Recipient Sex on Long‐Term Outcomes Following Living Donor Kidney Transplantation: A Retrospective Dual‐Center Study
por: Yitian Fang, et al.
Publicado: (2025)
por: Yitian Fang, et al.
Publicado: (2025)
Higher Hospitalization Costs and Fewer Routine Discharges in the Medicaid Expansion Era for Lung Transplant Recipients
por: Andrew Kalra, et al.
Publicado: (2024)
por: Andrew Kalra, et al.
Publicado: (2024)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
por: Eishan Ashwat, et al.
Publicado: (2025)
por: Eishan Ashwat, et al.
Publicado: (2025)
Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience
por: U. Mathuram Thiyagarajan, et al.
Publicado: (2025)
por: U. Mathuram Thiyagarajan, et al.
Publicado: (2025)
Ejemplares similares
-
Association of Community Distress With Lung Transplant Waitlist Acceptance
por: William M. Brandon, et al.
Publicado: (2025) -
Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience
por: Colin T. Dunn, et al.
Publicado: (2024) -
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025) -
Failed Extubation After Lung Transplantation in the United States: A Six‐Year National Analysis Using the UNOS Database
por: Amit Banga, et al.
Publicado: (2026) -
Characteristics and Clinical Outcomes of Postoperative Pleural Space Infections Among Lung Transplant Recipients
por: Miranda Arzate, et al.
Publicado: (2026)